3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Inositol
6
follitropin alfa
4
Glycoprotein Hormones, alpha Subunit
3
follitropin beta
2
Metformin
2
Letrozole
2
DLBS3233
2
Clomiphene
2
Chorionic Gonadotropin
2
licogliflozin
1
elagolix
1
cetrorelix
1
Urofollitropin
1
Secretome
1
Progesterone
1
Oils
1
Menotropins
1
Leuprolide
1
Lactalbumin
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Itraconazole
1
Folic Acid
1
Diosgenin
1
Contraceptives, Oral
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Polycystic Ovary Syndrome
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts